Searchable abstracts of presentations at key conferences in endocrinology

ea0077p250 | Thyroid | SFEBES2021

A case of autoimmune hyperthyroidism in pregnancy after COVID-19 vaccine

Varughese Maria S , Nayak Ananth U

A 36-year-old lady presented at 26-weeks gestation with symptoms of palpitations, anxiety, tremors, and breathlessness. She had received the 1st dose of the mRNA vaccine (Pfizer) for Covid-19 a month prior and her symptoms started a couple of weeks after the vaccine. She was a gravida 4 para 2 with gestational diabetes diagnosed during previous pregnancies and also early on in the current pregnancy requiring insulin treatment maintaining excellent antenatal glycaemic control. ...

ea0044p254 | Thyroid | SFEBES2016

An Audit on Fixed dose (555 MBq) Radioactive-iodine for Hyperthyroidism at a University Hospital

Vijay Arun Muthukaruppan Alagar , Cooper Julie , Varadhan Lakshminarayanan , Nayak Ananth U

Background/Aim: Radioactive-iodine (RAI) therapy aims to cure hyperthyroidism, with some International authorities recommending a sufficient RAI dose to render patients hypothyroid. An audit on low dose RAI (<400 MBq) at our University Hospital in 2014 suggested above national average rates of Thyrotoxicosis relapse (24%) and lower rates of hypothyroidism (41%) 6-months post RAI. From 2015, a fixed dose (555 MBq) RAI was utilised and we present the audit outcomes using thi...